FMC

FMC

Capitalización de mercado USD 880 M

FMC Corporation sold roughly $403 million of newly issued shares in September 2026 and previously announced a $1.2 billion senior secured notes offering before cutting its Q3 2026 revenue outlook from $840 million to $900 million down to $65 million to $125 million. The investigation focuses on the Company's SEC-reported offering disclosures.

FMC's steep selloff hasn't erased concerns about its debt and inventory problems, while rival Corteva looks more attractive.

FMC Corp. (NYSE:FMC) faces mounting pressure from cheaper generic pesticides, weak agricultural demand and elevated debt, prompting RBC Capital Markets to lower its price forecast ahead of the company's third-quarter earnings.

BOSTON, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating FMC (NYSE: FMC) for potential securities law violations. Investors who have lost money in their FMC investment should contact the firm to learn more about how they might recover those losses.

Boston, Massachusetts--(Newsfile Corp. - October 15, 2026) - Block & Leviton is investigating FMC (NYSE: FMC) for potential securities law violations. Investors who have lost money in their FMC investment should contact the firm to learn more about how they might recover those losses.

ATLANTA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) complied with federal securities laws. On October 15, 2026, FMC provided an update to its third-quarter expectations, projecting that revenue for the quarter is now expected to be $65 to $125 million, with Adjusted EBITDA expected to be negative $565 million to negative $510 million. The Company disclosed that “Third-quarter demand was weaker than we expected, driven by challenging market conditions and elevated levels of higher-priced FMC products held in inventory by certain channel customers, which are limiting product movement and replenishment demand[.]” On this news, the price of the Company's stock dropped.

Shares of crop chemical maker FMC plunged Thursday after the company provided deeply disappointing guidance.

Third-quarter revenue 1 is now expected to be $65 million to $125 million, with Adjusted EBITDA 2 expected to be negative $565 million to negative $510 million Revised expectations now include commercial actions which are resulting in approximately $625 million to $675 million in charges impacting revenue 1 and Adjusted EBITDA 2 Commercial actions are expected to accelerate movement of FMC products through the channel, supporting future replenishment demand PHILADELPHIA, Oct. 15, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC) today updated its expectations for third quarter 2026.  Revenue1 is now expected to be between $65 million and $125 million with expected Adjusted EBITDA2 of negative $565 million to negative $510 million.

Chemical stocks are flashing some of the highest dividend yields in the sector right now, but the number your screener shows and the check you will actually receive are not the same thing, and the gap between them hides a

FMC submits rimisoxafen for regulatory approval in Brazil, advancing a dual-mode-of-action herbicide aimed at resistant broadleaf weeds in major crops.